Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.

Interferon (IFN) therapy of early chronic myelogenous leukemia (CML) frequently produces partial or complete cytogenetic remission of the disease. Patients with complete cytogenetic remission often continue on therapy for several years with bone marrow showing only diploid (normal) metaphases. We studied hematopoiesis in five female patients with major cytogenetic remissions from CML during IFN therapy. Clonality analysis using the BstXI PGK gene polymorphism showed that granulocytes were nonclonal in all patients during cytogenetic remission. BCR region studies showed rearrangement only in the one patient whose remission was incomplete at the time of sampling. Granulopoiesis is nonclonal in IFN-induced remissions of CML and may be derived from normal hematopoietic stem cells.

[1]  H. Kantarjian,et al.  Strategy for breakpoint cluster region analysis in chronic myelocytic leukemia in a routine clinical laboratory. , 1990, American journal of clinical pathology.

[2]  R Storb,et al.  Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation. , 1988, Blood.

[3]  J U Gutterman,et al.  The molecular genetics of Philadelphia chromosome-positive leukemias. , 1988, The New England journal of medicine.

[4]  H. Willard,et al.  Clonal analysis using recombinant DNA probes from the X-chromosome. , 1987, Cancer research.

[5]  H. Kantarjian,et al.  Clonal nature of Philadelphia chromosome-positive and -negative chronic myelogenous leukemia by DNA hybridization analyses. , 1987, Experimental hematology.

[6]  H. Kantarjian,et al.  Clinical investigation of human alpha interferon in chronic myelogenous leukemia. , 1987, Blood.

[7]  C. Eaves,et al.  Nonclonal hemopoietic progenitors in a G6PD heterozygote with chronic myelogenous leukemia revealed after long‐term marrow culture , 1987, American journal of hematology.

[8]  L. Kearney,et al.  Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL. , 1986, Cancer genetics and cytogenetics.

[9]  H. Kantarjian,et al.  Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. , 1986, The New England journal of medicine.

[10]  H. Kantarjian,et al.  T-cell involvement in benign phase chronic myelogenous leukemia. , 1986, Leukemia research.

[11]  S. Jhanwar,et al.  Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. , 1985, Blood.

[12]  M. Groudine,et al.  Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. , 1984, Science.

[13]  C. Eaves,et al.  Cytogenetic studies of early myeloid progenitor compartments in Ph1‐positive chronic myeloid leukaemia (CML) I. PERSISTENCE OF Ph1‐NEGATIVE COMMITTED PROGENITORS THAT ARE SUPPRESSED FROM DIFFERENTIATING IN VIVO , 1984, British journal of haematology.

[14]  J. Stephenson,et al.  Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia , 1983, Nature.

[15]  J. Gutterman,et al.  Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. , 1983, Blood.

[16]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[17]  E. Reinherz,et al.  T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia. , 1983, Blood.

[18]  D. Rosenthal,et al.  Differentiation patterns in the blastic phase of chronic myeloid leukemia. , 1983, Blood.

[19]  P. Hernández,et al.  CHRONIC MYELOID LEUKAEMIA BLAST CRISIS WITH T‐CELL FEATURES , 1982, British journal of haematology.

[20]  J. Burchenal,et al.  Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment. , 1982, Blood.

[21]  V. Najfeld,et al.  Evidence for a multistep pathogenesis of chronic myelogenous leukemia. , 1981, Blood.

[22]  J. Adamson,et al.  Chronic myelogenous leukemia: in vitro studies of hematopoietic regulation in a patient undergoing intensive chemotherapy. , 1981, The Journal of clinical investigation.

[23]  V. Najfeld,et al.  Involvement of the B-lymphoid system in chronic myelogenous leukaemia , 1980, Nature.

[24]  J. Adamson,et al.  Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome. , 1980, Blood.

[25]  A. Cork,et al.  Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. , 1979, Blood.

[26]  A. Denman,et al.  Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. , 1978, The Journal of clinical investigation.

[27]  A. Denman,et al.  ORIGIN OF SOME LYMPHOCYTES FROM LEUKEMIC STEM CELLS , 1978 .